Showing results (171-180 of 254) with videos related to

Sort By:
Pageof 26
Antimicrobial Agents and Chemotherapy|January 7, 2009
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein revValentina Svicher, Claudia Alteri, Roberta D'Arrigo, et al.
BMC Infectious Diseases|October 13, 2023
EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestationsBenedetta Varisco, Francesca Bai, Sara De Benedittis, et al.
Virology Journal|August 15, 2021
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021Alessia Lai, Annalisa Bergna, Stefano Menzo, et al.
Plos One|August 26, 2014
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAARTDaniele Armenia, Cathia Soulie, Domenico Di Carlo, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individualsAlex Durand Nka, Yagai Bouba, Georges Teto, et al.
AIDS Research and Human Retroviruses|March 16, 2012
Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in ItalyMaria Mercedes Santoro, Claudia Alteri, Luigi Ronga, et al.
Microorganisms|November 21, 2020
Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV MarkersRomina Salpini, Vincenzo Malagnino, Lorenzo Piermatteo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 1, 2015
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practiceValeria Cento, Monica Tontodonati, Velia Chiara Di Maio, et al.
Le Infezioni in Medicina|June 1, 2021
Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019Barbara Rossetti, Lorenzo Paglicci, Velia C Di Maio, et al.
Viruses|January 22, 2022
The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral FailuresStephanie Popping, Valeria Cento, Carole Seguin-Devaux, et al.
Pageof 26